Cargando…

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study

OBJECTIVES: To determine whether time elapsed since the second injection of the Pfizer-BioNTech BNT162b2 mRNA vaccine was significantly associated with the risk of covid-19 infection after vaccination in people who received two vaccine injections. DESIGN: Test negative design study. SETTING: Electro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Israel, Ariel, Merzon, Eugene, Schäffer, Alejandro A, Shenhar, Yotam, Green, Ilan, Golan-Cohen, Avivit, Ruppin, Eytan, Magen, Eli, Vinker, Shlomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083235/ https://www.ncbi.nlm.nih.gov/pubmed/34819275 http://dx.doi.org/10.1136/bmj-2021-067873

Ejemplares similares

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
por: Israel, Ariel, et al.
Publicado: (2021)

Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
por: Israel, Ariel, et al.
Publicado: (2021)

Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
por: Israel, Ariel, et al.
Publicado: (2021)

Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination
por: Israel, Ariel, et al.
Publicado: (2022)

Predicting COVID-19 severity using major risk factors and received vaccines
por: Israel, Ariel, et al.
Publicado: (2022)

A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received
por: Israel, Ariel, et al.
Publicado: (2022)

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Long-Term Risk of Immune-Related diseases
por: Israel, Ariel, et al.
Publicado: (2023)

Glucose-6-phosphate dehydrogenase deficiency and long-term risk of immune-related disorders
por: Israel, Ariel, et al.
Publicado: (2023)

Selective IgA deficiency and COVID-19
por: Magen, Eli, et al.
Publicado: (2023)

COVID-19 Susceptibility in Bronchial Asthma
por: Green, Ilan, et al.
Publicado: (2021)

A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection
por: Green, Ilan, et al.
Publicado: (2022)

Author’s reply to comment on: A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection
por: Green, Ilan, et al.
Publicado: (2023)

The Association of Weight Reduction and Other Variables after Bariatric Surgery with the Likelihood of SARS-CoV-2 Infection
por: Frish, Noam, et al.
Publicado: (2023)

The Association between Previous Antibiotic Consumption and SARS-CoV-2 Infection: A Population-Based Case-Control Study
por: Dugot, Matan, et al.
Publicado: (2023)

The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
por: Merzon, Eugene, et al.
Publicado: (2022)

Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression
por: Lauden, Ari, et al.
Publicado: (2021)

The Effect of Antibiotic Treatment of Early Childhood Shigellosis on Long-Term Prevalence of Attention Deficit/Hyperactivity Disorder
por: Sadaka, Yair, et al.
Publicado: (2021)

Patient-level predictors of temporal regularity of primary care visits
por: Rose, Adam J., et al.
Publicado: (2023)

The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study
por: Brill, Gherta, et al.
Publicado: (2022)

Greater temporal regularity of primary care visits was associated with reduced hospitalizations and mortality, even after controlling for continuity of care
por: Khazen, Maram, et al.
Publicado: (2023)

The efficacy of single pharmacist medication review among type II diabetic patients who take six chronic medications or more: a case–control study
por: Harmatz, Danielle, et al.
Publicado: (2022)

ADHD as a Risk Factor for Infection With Covid-19
por: Merzon, Eugene, et al.
Publicado: (2020)

Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study
por: Merzon, Eugene, et al.
Publicado: (2022)

Early Childhood Shigellosis and Attention Deficit Hyperactivity Disorder: A Population-Based Cohort Study with a Prolonged Follow-up
por: Merzon, Eugene, et al.
Publicado: (2020)

Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
por: Magen, Eli, et al.
Publicado: (2022)

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022)

On the Cooling of Dead Bodies as Indicating the Length of Time That Has Elapsed Since Death
por: Rainy, Harry
Publicado: (1869)

A computational method to assess the time elapsed since exposure using thermoluminescence dosemeters
por: Furetta, C, et al.
Publicado: (1985)

Prognostic importance of atrial fibrillation in heart failure according to time elapsed since diagnosis
por: Schwartz, Brian, et al.
Publicado: (2022)

Relationship between time elapsed since completion of radiotherapy and quality of life of patients with breast cancer
por: Zhang, Jing-Jie, et al.
Publicado: (2018)

BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
por: Rahav, Galia, et al.
Publicado: (2021)

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Machine Learning Classification of Time since BNT162b2 COVID-19 Vaccination Based on Array-Measured Antibody Activity
por: Ma, Qing-Lan, et al.
Publicado: (2023)

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19
por: de Michelena, Paula, et al.
Publicado: (2022)

BNT162b2 Vaccine Booster and Mortality Due to Covid-19
por: Arbel, Ronen, et al.
Publicado: (2021)

Immunogenicity of a BNT162b2 vaccine booster in health-care workers
por: Saiag, Esther, et al.
Publicado: (2021)

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
por: Magen, Ori, et al.
Publicado: (2022)

Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset?
por: Berthelot, Jean-Marie, et al.
Publicado: (2019)

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
por: Cohen-Stavi, Chandra J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8p4umnvcejf26rkrspn2olc5co